<DOC>
	<DOCNO>NCT00216086</DOCNO>
	<brief_summary>Preoperative induction chemotherapy successfully use variety malignancy provide several advantage postoperative therapy . Combination 5-FU/Leucovorin/CPT-11 demonstrate significantly good response rate 5-FU/Leucovorin alone . Replacing 5-FU oral capecitabine combination CPT-11 emerge potentially effective , safe convenient treatment option metastatic colorectal cancer . Capecitabine also well tolerated concurrent treatment radiation . Recent data show preoperative radiation appear significantly effective increase resectability rate . This trial investigate activity capecitabine CPT-11 combination preoperative setting follow chemoradiation capecitabine locally advanced rectal cancer improve response decrease local recurrence . We also study whether TS , TP , DPD carboxyesterase expression correlate objective response rate chemotherapy chemoradiation regimen .</brief_summary>
	<brief_title>Capecitabine + Irinotecan Followed Combined Modality Capecitabine Radiation Locally Advanced Rectal Cancer</brief_title>
	<detailed_description>OUTLINE : This multi-center study . Biopsy per EUS - Irinotecan 200 mg/m2 IV , day 1 - Capecitabine 1000* mg/m2 PO BID day 1-14 Repeat every three week two cycles* For calculated creatinine clearance 30-50 mL/min patient &gt; 70years old , capecitabine start dose 825 mg/m2 PO BID Beginning week 7 follow recovery chemotherapy : - Pelvic XRT 45 Gy/1.8 Gy/fx/qd+5.4 Gy/1.8 Gy/fx/qd T3+9 Gy/1.8 Gy/fx/qd T4 - Capecitabine 825* mg/m2 PO BID , 5 days/week , throughout XRT* For calculated creatinine clearance 30-50 mL/min patient &gt; 70years old , capecitabine start dose 650 mg/m2 PO BID - Surgery within 8weeks follow chemoradiotherapy - Adjuvant Chemotherapy investigator 's discretion ECOG performance status 0 1 Hematopoietic : · - ANC count &gt; 1,500 mm3· - Platelets &gt; 100,000/mm3· - Hemoglobin &gt; 9g/dL - Prothrombin time ( PT ) /INR PTT &lt; 1.25 time upper limit normal ; Hepatic : · - Bilirubin &lt; 1.5 time upper limit normal - Alanine Transaminase ( ALT ) Aspartate Transaminase ( AST ) &lt; 2.5 time upper limit normal Renal : · - Adequate renal function calculate creatinine clearance &gt; 30 mL/min ( Cockroft Gault ) Cardiovascular : · - No congestive heart failure require therapy NYHA class II great active angina know myocardial infarction within 12 month prior study</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>Histologically confirm adenocarcinoma rectum &lt; 15 cm anal verge without evidence distant metastasis· Measurable disease . · Either mobile cancer ( clinical stage T3 T4 endorectal ultrasound ) fix cancer ( defined clinical T4 study ) palpation . · Malignant disease may extend anal canal ( across dentate line ) No prior chemotherapy radiation therapy pelvis . Patients clinical stage T 12 , N0 rectal cancer candidate primary resection eligible· No synchronous colonic cancer unless synchronous tumor Tis T1 completely resected· Patients must take warfarin· No prior unanticipated severe reaction fluoropyrimidine therapy , know sensitivity 5Fluorouracil know DPD deficiency.· No known exist uncontrolled coagulopathy· Negative pregnancy test· No current breastfeeding· No serious concomitant systemic disorder incompatible study· No prior malignancy exception curatively treat basal squamous carcinoma skin , carcinoma insitu cervix , cancer patient diseasefree &lt; 5 years.· Patients must treat follow protocol therapy within 28 day prior begin protocol therapy : sorivudine , brivudine , cimetidine , allopurinol . Patients dilantin must regular monitoring dilantin level .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Rectal Cancer</keyword>
</DOC>